Skip navigation
Agenda

Real-Time Policy Briefings, Impactful Managed Market Trends and Strategies to Ensure Product Access

August 13-14, 2019
  • Philadelphia, PA

Agenda

Want more agenda details? Download the brochure.

DAY ONE — TUESDAY, AUGUST 13, 2019

7:30

Conference Registration and Networking Breakfast

8:30

Chairperson’s Welcome and Opening Remarks

Colette Flack
Senior Director, Patient Support Services,
Dermira

8:45

STATE OF THE INDUSTRY Political and Legislative Trends Impacting Healthcare Coverage and Access

Christina Sandefur
Executive Vice President
Goldwater Institute

9:30

Assess Potential for Changes to Pharmaceutical Pricing, Discounting, and Reimbursement for the Future

Ross Margulies
Associate
Foley Hoag LLP

10:15

Networking and Refreshment Break Hosted By:

10:45

PANEL Realign Access Strategies to Overcome Challenges of Copay Assistance and PBM Restrictions

MODERATOR:

Rujul Desai
Of Counsel
Covington & Burling LLP

PANELISTS:

Stacey Worthy
Counsel
Aimed Alliance

Kollet Koulianos, MBA
Senior Director, Payer Relations
National Hemophilia Foundation

Christina Simmons
Senior Corporate Counsel
Pfizer Inc

Saiza Elayda, JD
Director, State and Policy
PhRMA

11:30

COMPLIANCE SPOTLIGHT Trends in Enforcement and Oversight —
What Companies Can Do to Ensure Compliance

Anthony Scicchitano
Assistant U.S. Attorney
U.S. Attorney’s Office for the Eastern District of Pennsylvania

Jacob Elberg
Associate Professor
Seton Hall University School of Law

12:15

Networking Luncheon

1:30

New Product Launch in the Era of Precision Medicine

Marc Duey
Founder, President and CEO
ProMetrics

2:15

PANEL Manufacturer Spotlight —
Forward-Thinking Strategies to Ensure Market Access and Adherence

MODERATOR:

William Daniels
Director, Business and Market Segment Development
Conduent

PANELISTS:

Douglas Neely, CMPE
Head, Global Market Access
Athenex Oncology

Gergana Zlateva
Vice President, Payer Insights and Access
Pfizer Inc

Colette Flack
Senior Director, Patient Support Services,
Dermira

3:00

Networking and Refreshment Break

3:30 CHOOSE BETWEEN TWO SUMMITS (1-2)

1 Medicare and Marketplace Coverage Policies Impacting Access

Mallory O’Connor
Director, Public Policy, Mallinckrodt Pharmaceuticals;
former Director, Healthcare Policy & Federal Programs, BIO

2 Medical Device Coverage and Reimbursement

Timothy Kringel
Senior Vertical Solutions Consultant
LexisNexis Risk Solutions

4:30 CHOOSE BETWEEN TWO SUMMITS (3-4)

3 New Product Commercialization/Launch Scenario Planning

Jeff Henderson
Vice President, Head of Market Access and Government Affairs
Sobi, Inc.

Tami Carten
Executive Director, Market Access
Braeburn

4 Patient Assistance Compliance and Oversight

Rujul Desai
Of Counsel
Covington & Burling LLP

5:30

Close of Day One

Networking, Wine & Cheese Reception immediately following the final session on day one

DAY TWO — WEDNESDAY, AUGUST 14, 2019

8:00

Networking Breakfast

8:30

Conference Chairperson’s Review of Day One

Colette Flack
Senior Director, Patient Support Services,
Dermira

8:45

Changing Landscape for Prior Authorization and Reimbursement Support — Reexamining the Roles of the Manufacturer and Pharmacy

Jesse C. Dresser, Esq.
Partner
Frier Levitt, LLC

9:30

Trends in Benefit Design and the Continued Shift to High Deductible Plans

Gregory Gierer
Senior Vice President, Policy
America’s Health Insurance Plans (AHIP)

Alex Keeton
Director, Policy Research and Analytics
BIO

10:15

Pathways to Improvement — Insight on Achieving a Value-Driven,
Transparent and Affordable Healthcare System

J. Gabriel McGlamery, JD
Senior HCR Policy Consultant
Florida Blue

11:00

Networking and Refreshment Break Hosted By:

11:30 CHOOSE BETWEEN TWO TOPIC INTENSIVES (A-B)

A Paving the Way for Global Access and Commercialization

Stuart Bell
Vice President Consulting, Medicines Access
Inceptua Ltd

B Biosimilar Policy Evolution and Access Strategy

Molly Burich, MS
Director, Public Policy – Biosimilars and Reimbursement
Boehringer Ingelheim

12:15

Networking Luncheon

1:15 CHOOSE BETWEEN TWO TOPIC INTENSIVES (C-D)

C The Role and Growing Use of Digital Therapeutics by Payers, IDNs and Health Systems

Everett Crosland
Vice President, Market Access, Reimbursement and Government Affairs
AppliedVR

Andy Molnar
Senior Director, Market Access
Cognoa

D Building Value and Establishing Market Access Pathways for Cell and Gene Therapies

Nick Li, PhD, MBA
Senior Director, Health Economics and Outcomes Research
uniQure

2:00

Payer Negotiations for Improved Profitability —
A Role Play Exercise

Murray Kay
former SVP & Chief Financial Officer, Solvay Pharmaceuticals;
former Commercial Controller, AbbVie & Abbott Laboratories

2:45

Close of Conference

Agenda

Want more agenda details? Download the brochure.

Want more agenda details? Download the brochure.

DAY ONE — TUESDAY, AUGUST 13, 2019

7:30

Conference Registration and Networking Breakfast

8:30

Chairperson’s Welcome and Opening Remarks

Colette Flack
Senior Director, Patient Support Services,
Dermira

8:45

STATE OF THE INDUSTRY Political and Legislative Trends Impacting Healthcare Coverage and Access

Christina Sandefur
Executive Vice President
Goldwater Institute

9:30

Assess Potential for Changes to Pharmaceutical Pricing, Discounting, and Reimbursement for the Future

Ross Margulies
Associate
Foley Hoag LLP

10:15

Networking and Refreshment Break Hosted By:

10:45

PANEL Realign Access Strategies to Overcome Challenges of Copay Assistance and PBM Restrictions

MODERATOR:

Rujul Desai
Of Counsel
Covington & Burling LLP

PANELISTS:

Stacey Worthy
Counsel
Aimed Alliance

Kollet Koulianos, MBA
Senior Director, Payer Relations
National Hemophilia Foundation

Christina Simmons
Senior Corporate Counsel
Pfizer Inc

Saiza Elayda, JD
Director, State and Policy
PhRMA

11:30

COMPLIANCE SPOTLIGHT Trends in Enforcement and Oversight —
What Companies Can Do to Ensure Compliance

Anthony Scicchitano
Assistant U.S. Attorney
U.S. Attorney’s Office for the Eastern District of Pennsylvania

Jacob Elberg
Associate Professor
Seton Hall University School of Law

12:15

Networking Luncheon

1:30

New Product Launch in the Era of Precision Medicine

Marc Duey
Founder, President and CEO
ProMetrics

2:15

PANEL Manufacturer Spotlight —
Forward-Thinking Strategies to Ensure Market Access and Adherence

MODERATOR:

William Daniels
Director, Business and Market Segment Development
Conduent

PANELISTS:

Douglas Neely, CMPE
Head, Global Market Access
Athenex Oncology

Gergana Zlateva
Vice President, Payer Insights and Access
Pfizer Inc

Colette Flack
Senior Director, Patient Support Services,
Dermira

3:00

Networking and Refreshment Break

3:30 CHOOSE BETWEEN TWO SUMMITS (1-2)

1 Medicare and Marketplace Coverage Policies Impacting Access

Mallory O’Connor
Director, Public Policy, Mallinckrodt Pharmaceuticals;
former Director, Healthcare Policy & Federal Programs, BIO

2 Medical Device Coverage and Reimbursement

Timothy Kringel
Senior Vertical Solutions Consultant
LexisNexis Risk Solutions

4:30 CHOOSE BETWEEN TWO SUMMITS (3-4)

3 New Product Commercialization/Launch Scenario Planning

Jeff Henderson
Vice President, Head of Market Access and Government Affairs
Sobi, Inc.

Tami Carten
Executive Director, Market Access
Braeburn

4 Patient Assistance Compliance and Oversight

Rujul Desai
Of Counsel
Covington & Burling LLP

5:30

Close of Day One

Networking, Wine & Cheese Reception immediately following the final session on day one

DAY TWO — WEDNESDAY, AUGUST 14, 2019

8:00

Networking Breakfast

8:30

Conference Chairperson’s Review of Day One

Colette Flack
Senior Director, Patient Support Services,
Dermira

8:45

Changing Landscape for Prior Authorization and Reimbursement Support — Reexamining the Roles of the Manufacturer and Pharmacy

Jesse C. Dresser, Esq.
Partner
Frier Levitt, LLC

9:30

Trends in Benefit Design and the Continued Shift to High Deductible Plans

Gregory Gierer
Senior Vice President, Policy
America’s Health Insurance Plans (AHIP)

Alex Keeton
Director, Policy Research and Analytics
BIO

10:15

Pathways to Improvement — Insight on Achieving a Value-Driven,
Transparent and Affordable Healthcare System

J. Gabriel McGlamery, JD
Senior HCR Policy Consultant
Florida Blue

11:00

Networking and Refreshment Break Hosted By:

11:30 CHOOSE BETWEEN TWO TOPIC INTENSIVES (A-B)

A Paving the Way for Global Access and Commercialization

Stuart Bell
Vice President Consulting, Medicines Access
Inceptua Ltd

B Biosimilar Policy Evolution and Access Strategy

Molly Burich, MS
Director, Public Policy – Biosimilars and Reimbursement
Boehringer Ingelheim

12:15

Networking Luncheon

1:15 CHOOSE BETWEEN TWO TOPIC INTENSIVES (C-D)

C The Role and Growing Use of Digital Therapeutics by Payers, IDNs and Health Systems

Everett Crosland
Vice President, Market Access, Reimbursement and Government Affairs
AppliedVR

Andy Molnar
Senior Director, Market Access
Cognoa

D Building Value and Establishing Market Access Pathways for Cell and Gene Therapies

Nick Li, PhD, MBA
Senior Director, Health Economics and Outcomes Research
uniQure

2:00

Payer Negotiations for Improved Profitability —
A Role Play Exercise

Murray Kay
former SVP & Chief Financial Officer, Solvay Pharmaceuticals;
former Commercial Controller, AbbVie & Abbott Laboratories

2:45

Close of Conference